Rajbir Sangha
Clinical Cardiac Electrophysiology · Lebanon, NHNPI 1417041831
Payments from drug & device makers
What this record shows
3 manufacturers reported payments, led by Medtronic at 58.4% of the total. Reporting peaked in 2023 at $527 and has fallen 79.8% since, to $107 in 2025.
Across 12 payments — averaging $92.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$646
- Boston Scientific$243
- Abbott$217
Across 24 payments — averaging $2059.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$49K
What the payments were for
- Travel & lodging$48844%
- Food & beverage$61956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $646 |
| Boston Scientific | 2 | $243 |
| Abbott | 5 | $217 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$606
- GENERAL - THERAPIES$107
How this compares
Too few clinical cardiac electrophysiology providers in New Hampshireto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 115 | $110,390 |
| XareltoRivaroxaban | 15 | $23,301 |
| Dofetilide | 38 | $11,660 |
| Metoprolol Succinate | 157 | $2,642 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 50 | $1,969 |
| Amiodarone Hcl | 14 | $1,674 |
| Flecainide Acetate | 32 | $1,503 |
| Dilt-XrDiltiazem Hcl | 11 | $459 |
| Metoprolol Tartrate | 17 | $126 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Lebanon
- Emily ZeitlerLebanon$175K
- Alfred LokaLebanon$6K
- Evan GroveLebanon$1K
- Mark GreenbergLebanon$112
- Jamie KimLondonderry$386K
- Dingxin QinManchester$55K
- Connor HaughManchester$25K
- Adam ChodoshConcord$7K
- Todd SilbersteinKeene$4K
- Clayton JonesConcord$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.